INTERNATIONAL PATENT: NARENDRAN, ARUMUGAVADIVEL FILES APPLICATION FOR "IDENTIFICATION, DESIGN AND VALIDATION OF A NEOANTIGEN-BASED PEPTIDE VACCINE FOR THE TREATMENT OF PAX3/PAX7-FKHR FUSION-POSITIVE ALVEOLAR RHABDOMYOSARCOMA"

GENEVA, April 17 -- NARENDRAN, Arumugavadivel (31 Country Lane TerraceCalgary, Alberta T3Z 1H8) filed a patent application (PCT/CA2025/051320) for "IDENTIFICATION, DESIGN, AND VALIDATION OF A NEOANTIGEN-BASED PEPTIDE VACCINE FOR THE TREATMENT OF PAX3/PAX7-FKHR FUSION-POSITIVE ALVEOLAR RHABDOMYOSARCOMA" on Oct 06, 2025. With publication no. WO/2026/076521, the details related to the patent application was published on Apr 16, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): SIPILA, Patrick (247 Arbour Wood Close NWCalgary, Alberta T3G 4B4)

Abstract: In some aspects there is described formulat...